Pulse Biosciences [PLSE] vs Becton, Dickinson [BDX] Detailed Stock Comparison

Pulse Biosciences Inc.

NASDAQ
Loading...

Becton, Dickinson and Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Pulse Biosciences Inc. wins in 2 metrics, Becton, Dickinson and Company wins in 16 metrics, with 0 ties. Becton, Dickinson and Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pulse Biosciences Inc. Becton, Dickinson and Company Better
P/E Ratio (TTM) N/A 25.40 N/A
Price-to-Book Ratio 20.17 1.75 Becton, Dickinson and Company
Debt-to-Equity Ratio 9.34 77.28 Pulse Biosciences Inc.
PEG Ratio -27.88 0.92 Becton, Dickinson and Company
EV/EBITDA -20.53 10.49 Becton, Dickinson and Company
Profit Margin (TTM) -54.00% 8.01% Becton, Dickinson and Company
Operating Margin (TTM) -6,914.02% 13.35% Becton, Dickinson and Company
EBITDA Margin (TTM) N/A 13.35% N/A
Return on Equity -74.45% 6.96% Becton, Dickinson and Company
Return on Assets (TTM) -42.37% 4.08% Becton, Dickinson and Company
Free Cash Flow (TTM) $-54.46M $2.67B Becton, Dickinson and Company
Dividend Yield N/A 2.56% N/A
1-Year Return 54.53% 8.01% Pulse Biosciences Inc.
Price-to-Sales Ratio (TTM) 4,658.22 2.57 Becton, Dickinson and Company
Enterprise Value $1.56B $63.40B Becton, Dickinson and Company
EV/Revenue Ratio 4,449.07 2.89 Becton, Dickinson and Company
Gross Profit Margin (TTM) 1.52% 45.91% Becton, Dickinson and Company
Revenue per Share (TTM) $0 $76 Becton, Dickinson and Company
Earnings per Share (Diluted) $-1.08 $6.13 Becton, Dickinson and Company
Beta (Stock Volatility) 1.69 0.35 Becton, Dickinson and Company
Short % of Float 16.20% 3.78% Becton, Dickinson and Company

Pulse Biosciences Inc. vs Becton, Dickinson and Company Stock Performance Analysis

Loading Price Chart...

PLSE
BDX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pulse Biosciences Inc.6.38%4.35%5.58%18.74%83.44%93.58%
Becton, Dickinson and Company-0.49%-2.98%1.43%-9.20%-7.49%-5.04%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pulse Biosciences Inc.54.53%288.68%40.54%457.67%490.07%490.07%
Becton, Dickinson and Company8.01%-28.08%-20.73%15.00%123.99%212.28%

Performance & Financial Health Analysis: Pulse Biosciences Inc. vs Becton, Dickinson and Company

MetricPLSEBDX
Market Information
Market Cap i$1.65B$56.10B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i241,7102,759,250
90 Day Avg. Volume i269,6532,521,130
Last Close$25.92$145.52
52 Week Range$12.56 - $28.53$127.59 - $187.35
% from 52W High-9.13%-22.33%
All-Time High$45.82 (Feb 08, 2021)$287.32 (Jul 24, 2023)
% from All-Time High-43.43%-49.35%
Growth Metrics
Quarterly Revenue Growth2.07%0.02%
Quarterly Earnings GrowthN/A0.26%
Financial Health
Profit Margin (TTM) i-0.54%0.08%
Operating Margin (TTM) i-69.14%0.13%
Return on Equity (TTM) i-0.74%0.07%
Debt to Equity (MRQ) i9.3477.28
Cash & Liquidity
Book Value per Share (MRQ)$1.19$88.79
Cash per Share (MRQ)$1.19$2.64
Operating Cash Flow (TTM) i$-54,122,000$3.39B
Levered Free Cash Flow (TTM) i$-29,515,876$3.11B
Dividends
Last 12-Month Dividend Yield iN/A2.56%
Last 12-Month Dividend iN/A$4.18

Valuation & Enterprise Metrics Analysis: Pulse Biosciences Inc. vs Becton, Dickinson and Company

MetricPLSE (Apr 24, 2026)BDX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A25.40
Forward P/E i-27.8811.53
PEG Ratio i-27.880.92
Price to Sales (TTM) i4,658.222.57
Price to Book (MRQ) i20.171.75
Market Capitalization
Market Capitalization i$1.65B$56.10B
Enterprise Value i$1.56B$63.40B
Enterprise Value Metrics
Enterprise to Revenue i4,449.072.89
Enterprise to EBITDA i-20.5310.49
Risk & Other Metrics
Beta i1.690.35
Book Value per Share (MRQ) i$1.19$88.79

Financial Statements Comparison: Pulse Biosciences Inc. vs Becton, Dickinson and Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPLSE (2025)BDX (2025)
Revenue/Sales i350,00021.84B
Cost of Goods Sold i539,00011.92B
COGS % of Revenue i154.0%54.6%
Gross Profit i-189,0009.93B
Gross Margin i-54.0%45.4%
Research & Development i44.72M1.27B
Operating Income (EBIT) i-76.94M2.99B
Operating Margin i-21,982.6%13.7%
EBITDA i-75.87M5.42B
EBITDA Margin i-21,676.6%24.8%
Pre-Tax Income i-72.78M1.88B
Pre-Tax Income % of Revenue i-20,794.6%8.6%
Income Tax iN/A203.00M
Income Tax % of Revenue i0.0%0.9%
Net Income (Profit) i-72.78M1.68B
Profit Margin i-20,794.6%7.7%

Balance Sheet & Liquidity Metrics

MetricPLSE (2025)BDX (2025)
Cash & Equivalents i80.74M641.00M
Total Current Assets i83.42M9.26B
Total Current Assets % of Revenue i23,834.6%42.4%
Total Current Liabilities i7.92M8.31B
Total Current Liabilities % of Revenue i2,263.7%38.1%
Long-Term Debt i5.96M17.62B
Long-Term Debt % of Revenue i1,702.9%80.7%
Total Shareholders Equity i80.66M25.39B
Retained Earnings i-463.28M16.62B
Retained Earnings % of Revenue i-132,366.0%76.1%
Property, Plant & Equipment i7.64M0

Cash Flow Statement Comparison

MetricPLSE (2025)BDX (2025)
Operating Cash Flow i-49.76M3.68B
Operating Cash Flow % of Revenue i-14,217.1%16.9%
Capital Expenditures i-315,000N/A
Free Cash Flow i-54.46M2.67B
FCF Margin i-15,559.1%12.2%
Debt Repayment iN/A-1.79B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPLSEBDX
Shares Short i2.92M9.49M
Short Ratio i11.203.92
Short % of Float i16.20%3.78%
Shares Outstanding i67.84M284.74M
Float Shares i17.79M283.99M
% Held by Insiders i73.70%0.40%
% Held by Institutions i9.52%96.58%
% Held by Public i16.78%3.02%

Dividend Analysis & Yield Comparison: Pulse Biosciences Inc. vs Becton, Dickinson and Company

MetricPLSEBDX
Last 12-Month Dividend iN/A$4.18
Last 12-Month Dividend Yield iN/A2.56%
3-Year Avg Annual Dividend iN/A$3.96
3-Year Avg Dividend Yield iN/A0.58%
3-Year Total Dividends iN/A$11.88
Ex-Dividend DateN/AMar 10, 2026